Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Oct 31, 2025 | (FY)Oct 31, 2024 | (FY)Oct 31, 2023 | (FY)Oct 31, 2022 | (FY)Oct 31, 2021 | (Q4)Oct 31, 2021 | (FY)Oct 31, 2020 | (Q4)Oct 31, 2020 | (FY)Oct 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.02%30.69M | 51.72%31M | 130.25%20.43M | -43.94%8.87M | 6.77%15.83M | -50.86%3.32M | -21.34%14.83M | 6.75M | 18.85M |
| Cost of revenue | 1.83%26.5M | 45.21%26.02M | 116.21%17.92M | -22.84%8.29M | 0.32%10.74M | -50.50%2.59M | -24.88%10.71M | 5.24M | 14.26M |
| Gross profit | -15.85%4.19M | 98.21%4.98M | 329.10%2.51M | -88.50%585.18K | 23.53%5.09M | -52.14%725.2K | -10.37%4.12M | 1.52M | 4.59M |
| Operating expense | 4.51%2.92M | 21.33%2.79M | -13.23%2.3M | 17.80%2.65M | -13.82%2.25M | -53.91%399.7K | 4.62%2.61M | 867.27K | 2.5M |
| Selling and administrative expenses | -30.49%57K | 86.36%82K | -93.28%44K | 1,930.65%654.86K | -6.93%32.25K | 13.93%10.92K | 3.96%34.65K | --9.58K | --33.33K |
| -General and administrative expense | -30.49%57K | 86.36%82K | -93.28%44K | 1,930.65%654.86K | -6.93%32.25K | 13.93%10.92K | 3.96%34.65K | --9.58K | --33.33K |
| Other operating expenses | 5.57%2.86M | 20.06%2.71M | 13.01%2.26M | -9.99%2M | -13.91%2.22M | -54.67%388.78K | 4.63%2.58M | --857.69K | --2.46M |
| Operating profit | -41.90%1.27M | 944.98%2.18M | 110.11%209K | -172.95%-2.07M | 88.40%2.83M | -49.76%325.51K | -28.24%1.5M | 647.87K | 2.1M |
| Net non-operating interest income (expenses) | 36.45%-319K | -37.91%-502K | -164.16%-364K | -261.19%-137.8K | -1,692.24%-38.15K | 44.10%18.46K | 828.68%2.4K | 12.81K | 258 |
| Non-operating interest income | ---- | ---- | ---- | 50.81%47.59K | 74.39%31.55K | ---- | -11.17%18.09K | ---- | --20.37K |
| Non-operating interest expense | -36.45%319K | 37.91%502K | 96.35%364K | 165.96%185.38K | 344.03%69.7K | 147.89%13.09K | -21.94%15.7K | --5.28K | --20.11K |
| Net investment income | 1,221.57%37.49K | 2.84K | |||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||||||
| Income from associates and other participating interests | |||||||||
| Special income (charges) | 112.92%55.35K | -661.32%-428.48K | 76.33K | 0 | |||||
| Less:Other special charges | ---- | ---- | ---- | 35.64%-55.35K | -12.66%-86K | ---- | ---76.33K | ---- | ---- |
| Less:Write off | ---- | ---- | ---- | ---- | --514.47K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 229.31%382K | -27.95%116K | 375.98%161K | -1.67%33.83K | -8.99%34.4K | -4,700.81%-95.15K | 37.8K | -1.98K | |
| Income before tax | -25.97%1.33M | 29,866.67%1.8M | 100.29%6K | -186.43%-2.08M | 48.37%2.41M | -124.06%-176.82K | -22.69%1.62M | 735.04K | 2.1M |
| Income tax | 55.38%679K | 408.14%437K | 12.04%86K | -88.05%76.76K | 3,308.48%642.24K | -352.45%-15.23K | -206.60%-20.02K | 6.03K | 18.78K |
| Net income | -52.09%652K | 1,801.25%1.36M | 96.29%-80K | -222.27%-2.16M | 7.43%1.76M | -122.17%-161.59K | -21.03%1.64M | 729.01K | 2.08M |
| Net income continuous operations | -52.09%652K | 1,801.25%1.36M | 96.29%-80K | -222.27%-2.16M | 7.43%1.76M | -122.17%-161.59K | -21.03%1.64M | --729.01K | --2.08M |
| Noncontrolling interests | 0 | 0 | 0 | ||||||
| Net income attributable to the company | -52.09%652K | 1,801.25%1.36M | 96.29%-80K | -222.27%-2.16M | 7.43%1.76M | -122.17%-161.59K | -21.03%1.64M | 729.01K | 2.08M |
| Preferred stock dividends | |||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -52.09%652K | 1,801.25%1.36M | 96.29%-80K | -222.27%-2.16M | 7.43%1.76M | -122.17%-161.59K | -21.03%1.64M | 729.01K | 2.08M |
| Gross dividend payment | |||||||||
| Basic earnings per share | -50.94%0.0026 | 1,866.67%0.0053 | 96.94%-0.0003 | -241.74%-0.0098 | 7.43%0.0069 | -122.18%-0.0006 | -21.03%0.0064 | 0.0029 | 0.0082 |
| Diluted earnings per share | -50.94%0.0026 | 1,866.67%0.0053 | 96.94%-0.0003 | -241.74%-0.0098 | 7.43%0.0069 | -122.18%-0.0006 | -21.03%0.0064 | 0.0029 | 0.0082 |
| Dividend per share | 0.0078 | ||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.